找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Gastrointestinal Cancer; A Comprehensive Guid Hoon Jai Chun,Seun Ja Park,Si Young Song Book 2023 The Editor(s) (if applicable) and The Auth

[復制鏈接]
樓主: 能干
21#
發(fā)表于 2025-3-25 06:29:20 | 只看該作者
Prithvi Raj,Hans Nolte,Michael Stanton-Hicksclinical outcomes of radiation therapy alone are unsatisfactory and are not recommended as an option for first-line treatment. When radiotherapy and chemotherapy are combined, the local cure rate and survival rate improve greatly, and several clinical studies have been published showing clinical out
22#
發(fā)表于 2025-3-25 10:56:24 | 只看該作者
https://doi.org/10.1007/978-3-642-49157-3ncer have been gradually declining in recent decades, the most recent epidemiological study reports that gastric cancer is the fifth most common cancer, accounting for 5.6% of all cancers worldwide, while gastric cancer-related mortality is the fourth most common, accounting for 7.7% of all cancer-related mortality [1].
23#
發(fā)表于 2025-3-25 14:56:09 | 只看該作者
Ludwig Heilmeyer,Herbert Begemannchemotherapy and supportive care can be used for stage IV patients with distant metastases, as recommended by the Korean [1] and Japanese [2] guidelines established in 2018. Table 1 shows the stages, and Table 2 summarizes the treatment plans according to the clinical and pathological stages. Figures 1 and 2 illustrate the treatment algorithm.
24#
發(fā)表于 2025-3-25 16:34:47 | 只看該作者
Wolf-Dieter Heiss,Curt Beil,Klaus Wienhard, nodal involvement, and presence of metastases that make up the TNM staging classification. Optimal staging and optimal treatment decisions based on stage, histologic type, and location of the disease are very important.
25#
發(fā)表于 2025-3-25 22:45:07 | 只看該作者
26#
發(fā)表于 2025-3-26 04:05:49 | 只看該作者
27#
發(fā)表于 2025-3-26 06:32:37 | 只看該作者
28#
發(fā)表于 2025-3-26 11:23:10 | 只看該作者
,MR-Angiographie der supraaortalen Gef??e, the last treatment option. Compared to the best supportive care, palliative chemotherapy can significantly improve patient’s quality of life and survival [1]. This chapter will review the chemotherapy regimens currently available in these clinical settings.
29#
發(fā)表于 2025-3-26 16:39:45 | 只看該作者
30#
發(fā)表于 2025-3-26 19:24:23 | 只看該作者
 關于派博傳思  派博傳思旗下網站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網 吾愛論文網 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經驗總結 SCIENCEGARD IMPACTFACTOR 派博系數 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網安備110108008328) GMT+8, 2025-10-9 14:38
Copyright © 2001-2015 派博傳思   京公網安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
新和县| 剑川县| 内丘县| 富锦市| 瓮安县| 义乌市| 莱芜市| 虞城县| 资源县| 汤阴县| 金华市| 徐水县| 安丘市| 五台县| 青海省| 开封县| 武山县| 兰考县| 施甸县| 永德县| 府谷县| 云南省| 南京市| 云浮市| 肇庆市| 新和县| 河曲县| 达拉特旗| 察隅县| 漳州市| 岗巴县| 原平市| 鹤壁市| 金华市| 白山市| 临沭县| 江北区| 扶风县| 西吉县| 海安县| 夏邑县|